122 related articles for article (PubMed ID: 30321129)
1. The Changing Face of Synthetic Cannabinoids in Texas.
Maxwell JC
J Psychoactive Drugs; 2018; 50(4):281-286. PubMed ID: 30321129
[TBL] [Abstract][Full Text] [Related]
2. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB; Haywood T
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
[TBL] [Abstract][Full Text] [Related]
3. Adolescent synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB
Pediatr Emerg Care; 2012 Oct; 28(10):985-9. PubMed ID: 23023462
[TBL] [Abstract][Full Text] [Related]
4. Synthetic cannabinoid exposures reported to Texas poison centers.
Forrester MB; Kleinschmidt K; Schwarz E; Young A
J Addict Dis; 2011 Oct; 30(4):351-8. PubMed ID: 22026527
[TBL] [Abstract][Full Text] [Related]
5. Psychoactive substances--some new, some old: a scan of the situation in the U.S.
Maxwell JC
Drug Alcohol Depend; 2014 Jan; 134():71-77. PubMed ID: 24140401
[TBL] [Abstract][Full Text] [Related]
6. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds.
Sznitman SR; Pinsky-Talbi L; Salameh M; Moed T; Bentur Y
Int J Drug Policy; 2020 Mar; 77():102711. PubMed ID: 32126489
[TBL] [Abstract][Full Text] [Related]
7. Synthetic cathinone exposures reported to Texas poison centers.
Forrester MB
Am J Drug Alcohol Abuse; 2012 Nov; 38(6):609-15. PubMed ID: 22541001
[TBL] [Abstract][Full Text] [Related]
8. Synthetic cannabinoid and marijuana exposures reported to poison centers.
Forrester MB; Kleinschmidt K; Schwarz E; Young A
Hum Exp Toxicol; 2012 Oct; 31(10):1006-11. PubMed ID: 22859662
[TBL] [Abstract][Full Text] [Related]
9. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
[TBL] [Abstract][Full Text] [Related]
10. An outbreak of synthetic cannabinoid exposures reported to a regional poison center: "K2" identified as 5F-ADB.
Arens AM; Olives TD; Simpson NS; Laes JR; Anderson DL; Bangh SA; Lee SC; Martin S; Banister SD; Gerona RR; Cole JB
Clin Toxicol (Phila); 2019 Jan; 57(1):69-71. PubMed ID: 30430881
[No Abstract] [Full Text] [Related]
11. Cannabis and synthetic cannabinoid poison control center cases among adults aged 50+, 2009-2019.
Choi NG; Marti CN; DiNitto DM; Baker SD
Clin Toxicol (Phila); 2021 Apr; 59(4):334-342. PubMed ID: 32840426
[TBL] [Abstract][Full Text] [Related]
12. Synthetic cannabinoid use among a sample of individuals enrolled in community-based recovery programs: Are synthetic cannabinoids actually preferred to other drugs?
Smith KE; Staton M
Subst Abus; 2019; 40(2):160-169. PubMed ID: 30457960
[No Abstract] [Full Text] [Related]
13. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013-2015.
Smith KE; Bunting AM; Staton M; Walker R; Shalash S; Winston E; Pangburn K
J Psychoactive Drugs; 2017; 49(5):436-445. PubMed ID: 28813207
[TBL] [Abstract][Full Text] [Related]
14. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.
Law R; Schier J; Martin C; Chang A; Wolkin A;
MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):618-9. PubMed ID: 26068566
[TBL] [Abstract][Full Text] [Related]
15. Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.
Kasper AM; Ridpath AD; Arnold JK; Chatham-Stephens K; Morrison M; Olayinka O; Parker C; Galli R; Cox R; Preacely N; Anderson J; Kyle PB; Gerona R; Martin C; Schier J; Wolkin A; Dobbs T
MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1121-2. PubMed ID: 26447715
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoid use in New Zealand: a recent rebound.
Schep LJ; Slaughter RJ; Temple WA; Lambie BS; Gee P; Watts M; Gresham C
N Z Med J; 2012 Oct; 125(1364):114-6. PubMed ID: 23242407
[No Abstract] [Full Text] [Related]
17. Synthetic cannabinoid use in psychiatric patients and relationship to hospitalisation: A retrospective electronic case register study.
Hobbs M; Patel R; Morrison PD; Kalk N; Stone JM
J Psychopharmacol; 2020 Jun; 34(6):648-653. PubMed ID: 32108548
[TBL] [Abstract][Full Text] [Related]
18. Carisoprodol abuse in Texas, 1998-2003.
Forrester MB
J Med Toxicol; 2006 Mar; 2(1):8-13. PubMed ID: 18072105
[TBL] [Abstract][Full Text] [Related]
19. Spice, vulnerability, and victimization: Synthetic cannabinoids and interpersonal crime victimization among homeless adults.
Ellsworth JT
Subst Abus; 2022; 43(1):32-38. PubMed ID: 31697191
[TBL] [Abstract][Full Text] [Related]
20. Pesticide-related poison center exposures in children and adolescents aged ≤19 years in Texas, 2000-2013.
Trueblood AB; Forrester MB; Han D; Shipp EM; Cizmas LH
Clin Toxicol (Phila); 2016 Nov; 54(9):852-856. PubMed ID: 27352113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
